Structure

Physi-Chem Properties

Molecular Weight:  536.19
Volume:  511.054
LogP:  1.851
LogD:  2.039
LogS:  -2.379
# Rotatable Bonds:  10
TPSA:  181.44
# H-Bond Aceptor:  12
# H-Bond Donor:  5
# Rings:  4
# Heavy Atoms:  12

MedChem Properties

QED Drug-Likeness Score:  0.219
Synthetic Accessibility Score:  4.693
Fsp3:  0.538
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.09
MDCK Permeability:  6.155748997116461e-05
Pgp-inhibitor:  0.001
Pgp-substrate:  0.093
Human Intestinal Absorption (HIA):  0.913
20% Bioavailability (F20%):  0.666
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.253
Plasma Protein Binding (PPB):  75.54570770263672%
Volume Distribution (VD):  0.419
Pgp-substrate:  16.29537582397461%

ADMET: Metabolism

CYP1A2-inhibitor:  0.074
CYP1A2-substrate:  0.082
CYP2C19-inhibitor:  0.079
CYP2C19-substrate:  0.154
CYP2C9-inhibitor:  0.14
CYP2C9-substrate:  0.068
CYP2D6-inhibitor:  0.02
CYP2D6-substrate:  0.135
CYP3A4-inhibitor:  0.087
CYP3A4-substrate:  0.179

ADMET: Excretion

Clearance (CL):  2.843
Half-life (T1/2):  0.942

ADMET: Toxicity

hERG Blockers:  0.165
Human Hepatotoxicity (H-HT):  0.163
Drug-inuced Liver Injury (DILI):  0.207
AMES Toxicity:  0.065
Rat Oral Acute Toxicity:  0.189
Maximum Recommended Daily Dose:  0.307
Skin Sensitization:  0.903
Carcinogencity:  0.791
Eye Corrosion:  0.003
Eye Irritation:  0.032
Respiratory Toxicity:  0.761

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC296659

Natural Product ID:  NPC296659
Common Name*:   Luzonoside D
IUPAC Name:   methyl (1S,4aS,7S,7aS)-7-[[(Z)-3-(4-hydroxyphenyl)prop-2-enoyl]oxymethyl]-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
Synonyms:   luzonoside D
Standard InCHIKey:  COQOXCPEJJIULA-YITUERRASA-N
Standard InCHI:  InChI=1S/C26H32O12/c1-34-24(33)17-12-36-25(38-26-23(32)22(31)21(30)18(10-27)37-26)20-14(5-8-16(17)20)11-35-19(29)9-4-13-2-6-15(28)7-3-13/h2-4,6-7,9,12,14,16,18,20-23,25-28,30-32H,5,8,10-11H2,1H3/b9-4-/t14-,16-,18-,20-,21-,22+,23-,25+,26+/m1/s1
SMILES:  OC[C@H]1O[C@@H](O[C@@H]2OC=C([C@@H]3[C@H]2[C@H](CC3)COC(=O)/C=Cc2ccc(cc2)O)C(=O)OC)[C@@H]([C@H]([C@@H]1O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL486467
PubChem CID:   11785975
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0002049] Terpene glycosides
          • [CHEMONTID:0004081] Iridoid O-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO8076 Viburnum luzonicum Species Adoxaceae Eukaryota n.a. n.a. n.a. PMID[15568771]
NPO8076 Viburnum luzonicum Species Adoxaceae Eukaryota n.a. leaf n.a. PMID[15635247]
NPO8076 Viburnum luzonicum Species Adoxaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO8076 Viburnum luzonicum Species Adoxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 100000.0 nM PMID[511280]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC296659 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC202391
0.9645 High Similarity NPC96599
0.9577 High Similarity NPC117346
0.9577 High Similarity NPC240592
0.9429 High Similarity NPC184464
0.9429 High Similarity NPC251062
0.9375 High Similarity NPC289021
0.9375 High Similarity NPC158546
0.9357 High Similarity NPC186296
0.9348 High Similarity NPC220936
0.9348 High Similarity NPC31745
0.9252 High Similarity NPC475484
0.9241 High Similarity NPC475379
0.922 High Similarity NPC293154
0.9214 High Similarity NPC154262
0.9214 High Similarity NPC137501
0.9214 High Similarity NPC7518
0.9214 High Similarity NPC159387
0.9197 High Similarity NPC169398
0.9161 High Similarity NPC143246
0.9161 High Similarity NPC119773
0.9161 High Similarity NPC473147
0.9161 High Similarity NPC474268
0.9161 High Similarity NPC475539
0.9155 High Similarity NPC77922
0.9155 High Similarity NPC473281
0.9103 High Similarity NPC478234
0.9103 High Similarity NPC478236
0.9091 High Similarity NPC475528
0.9085 High Similarity NPC475213
0.9085 High Similarity NPC152796
0.9067 High Similarity NPC179914
0.906 High Similarity NPC475378
0.9028 High Similarity NPC212808
0.9021 High Similarity NPC63304
0.9021 High Similarity NPC194938
0.9 High Similarity NPC101686
0.9 High Similarity NPC65262
0.9 High Similarity NPC469364
0.8986 High Similarity NPC257847
0.8978 High Similarity NPC254819
0.8966 High Similarity NPC473149
0.8936 High Similarity NPC49597
0.8919 High Similarity NPC194705
0.8919 High Similarity NPC478235
0.8912 High Similarity NPC69367
0.8912 High Similarity NPC35097
0.8904 High Similarity NPC120728
0.8889 High Similarity NPC145847
0.8881 High Similarity NPC296643
0.8859 High Similarity NPC229354
0.8851 High Similarity NPC474620
0.8831 High Similarity NPC109990
0.8811 High Similarity NPC46644
0.8794 High Similarity NPC472132
0.8792 High Similarity NPC203664
0.875 High Similarity NPC187205
0.8714 High Similarity NPC470143
0.8714 High Similarity NPC322503
0.8699 High Similarity NPC210330
0.869 High Similarity NPC302286
0.869 High Similarity NPC116104
0.869 High Similarity NPC263397
0.869 High Similarity NPC88754
0.869 High Similarity NPC478250
0.869 High Similarity NPC237872
0.8675 High Similarity NPC478232
0.8662 High Similarity NPC471345
0.8636 High Similarity NPC208676
0.8636 High Similarity NPC130489
0.8608 High Similarity NPC21956
0.8591 High Similarity NPC161955
0.8582 High Similarity NPC114116
0.8571 High Similarity NPC235294
0.8571 High Similarity NPC46137
0.8571 High Similarity NPC478255
0.8571 High Similarity NPC281798
0.8571 High Similarity NPC469384
0.8551 High Similarity NPC45224
0.8551 High Similarity NPC471881
0.8551 High Similarity NPC106677
0.8551 High Similarity NPC288416
0.8551 High Similarity NPC35288
0.8551 High Similarity NPC156692
0.8551 High Similarity NPC173150
0.8551 High Similarity NPC471882
0.8526 High Similarity NPC476011
0.8523 High Similarity NPC189631
0.8523 High Similarity NPC23677
0.8516 High Similarity NPC474936
0.8516 High Similarity NPC138993
0.8514 High Similarity NPC37838
0.8514 High Similarity NPC320734
0.8506 High Similarity NPC475663
0.8506 High Similarity NPC286919
0.8503 High Similarity NPC478240
0.85 High Similarity NPC17567
0.8489 Intermediate Similarity NPC225307
0.8478 Intermediate Similarity NPC61181
0.8478 Intermediate Similarity NPC471157
0.8477 Intermediate Similarity NPC77310
0.8477 Intermediate Similarity NPC478249
0.8477 Intermediate Similarity NPC269914
0.8456 Intermediate Similarity NPC18789
0.8456 Intermediate Similarity NPC52097
0.8456 Intermediate Similarity NPC470330
0.844 Intermediate Similarity NPC138777
0.844 Intermediate Similarity NPC225384
0.844 Intermediate Similarity NPC246869
0.8435 Intermediate Similarity NPC469367
0.8435 Intermediate Similarity NPC204644
0.8429 Intermediate Similarity NPC469549
0.8429 Intermediate Similarity NPC253595
0.8417 Intermediate Similarity NPC103533
0.8411 Intermediate Similarity NPC179128
0.8411 Intermediate Similarity NPC12006
0.8411 Intermediate Similarity NPC147224
0.8411 Intermediate Similarity NPC116292
0.8411 Intermediate Similarity NPC267469
0.8411 Intermediate Similarity NPC87630
0.8406 Intermediate Similarity NPC126991
0.8406 Intermediate Similarity NPC83218
0.84 Intermediate Similarity NPC308178
0.8389 Intermediate Similarity NPC291153
0.8389 Intermediate Similarity NPC208293
0.8387 Intermediate Similarity NPC329997
0.8387 Intermediate Similarity NPC49173
0.8382 Intermediate Similarity NPC11724
0.838 Intermediate Similarity NPC471095
0.838 Intermediate Similarity NPC471066
0.8369 Intermediate Similarity NPC470122
0.8369 Intermediate Similarity NPC469705
0.8369 Intermediate Similarity NPC319995
0.8369 Intermediate Similarity NPC289415
0.8369 Intermediate Similarity NPC17968
0.8367 Intermediate Similarity NPC284957
0.8366 Intermediate Similarity NPC61604
0.8366 Intermediate Similarity NPC245615
0.8366 Intermediate Similarity NPC299706
0.8366 Intermediate Similarity NPC115466
0.8365 Intermediate Similarity NPC301910
0.8365 Intermediate Similarity NPC130730
0.8345 Intermediate Similarity NPC252114
0.8344 Intermediate Similarity NPC478242
0.8333 Intermediate Similarity NPC263829
0.8333 Intermediate Similarity NPC97240
0.8323 Intermediate Similarity NPC478248
0.8322 Intermediate Similarity NPC136608
0.8322 Intermediate Similarity NPC38420
0.8322 Intermediate Similarity NPC164172
0.8309 Intermediate Similarity NPC476872
0.8299 Intermediate Similarity NPC80098
0.8291 Intermediate Similarity NPC206815
0.8289 Intermediate Similarity NPC182350
0.8289 Intermediate Similarity NPC162569
0.8289 Intermediate Similarity NPC229882
0.8289 Intermediate Similarity NPC35160
0.8289 Intermediate Similarity NPC158635
0.8288 Intermediate Similarity NPC324262
0.8288 Intermediate Similarity NPC81515
0.8288 Intermediate Similarity NPC476383
0.8288 Intermediate Similarity NPC171134
0.8288 Intermediate Similarity NPC64141
0.8288 Intermediate Similarity NPC472350
0.8288 Intermediate Similarity NPC68092
0.8288 Intermediate Similarity NPC220942
0.8288 Intermediate Similarity NPC321638
0.8288 Intermediate Similarity NPC62800
0.8288 Intermediate Similarity NPC89105
0.8288 Intermediate Similarity NPC328273
0.8288 Intermediate Similarity NPC197316
0.8288 Intermediate Similarity NPC321184
0.8278 Intermediate Similarity NPC473138
0.8278 Intermediate Similarity NPC28776
0.8273 Intermediate Similarity NPC123704
0.8269 Intermediate Similarity NPC4747
0.8269 Intermediate Similarity NPC226759
0.8269 Intermediate Similarity NPC104275
0.8267 Intermediate Similarity NPC473867
0.8264 Intermediate Similarity NPC886
0.8264 Intermediate Similarity NPC471883
0.8264 Intermediate Similarity NPC287597
0.8264 Intermediate Similarity NPC34293
0.8258 Intermediate Similarity NPC156624
0.8258 Intermediate Similarity NPC38699
0.8258 Intermediate Similarity NPC172920
0.8255 Intermediate Similarity NPC471028
0.8252 Intermediate Similarity NPC473285
0.825 Intermediate Similarity NPC282551
0.8247 Intermediate Similarity NPC229548
0.8247 Intermediate Similarity NPC469699
0.8247 Intermediate Similarity NPC89693
0.8247 Intermediate Similarity NPC478241
0.8243 Intermediate Similarity NPC148080
0.8243 Intermediate Similarity NPC469623
0.8228 Intermediate Similarity NPC117943
0.8228 Intermediate Similarity NPC477627
0.8228 Intermediate Similarity NPC293568
0.8227 Intermediate Similarity NPC158673
0.8219 Intermediate Similarity NPC476376

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC296659 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8288 Intermediate Similarity NPD7266 Discontinued
0.8221 Intermediate Similarity NPD7685 Pre-registration
0.7925 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7763 Intermediate Similarity NPD4628 Phase 3
0.7736 Intermediate Similarity NPD8455 Phase 2
0.7712 Intermediate Similarity NPD6190 Approved
0.7669 Intermediate Similarity NPD7199 Phase 2
0.7651 Intermediate Similarity NPD7228 Approved
0.7635 Intermediate Similarity NPD7966 Clinical (unspecified phase)
0.7613 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7605 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7602 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD6355 Discontinued
0.7562 Intermediate Similarity NPD37 Approved
0.7547 Intermediate Similarity NPD4380 Phase 2
0.7546 Intermediate Similarity NPD6234 Discontinued
0.7545 Intermediate Similarity NPD3818 Discontinued
0.7532 Intermediate Similarity NPD1653 Approved
0.7531 Intermediate Similarity NPD4966 Approved
0.7531 Intermediate Similarity NPD4967 Phase 2
0.7531 Intermediate Similarity NPD4965 Approved
0.75 Intermediate Similarity NPD7054 Approved
0.7485 Intermediate Similarity NPD7075 Discontinued
0.7471 Intermediate Similarity NPD6559 Discontinued
0.747 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD7074 Phase 3
0.7456 Intermediate Similarity NPD7472 Approved
0.7455 Intermediate Similarity NPD8127 Discontinued
0.7447 Intermediate Similarity NPD9545 Approved
0.7417 Intermediate Similarity NPD6653 Approved
0.7384 Intermediate Similarity NPD8313 Approved
0.7384 Intermediate Similarity NPD8312 Approved
0.7383 Intermediate Similarity NPD3764 Approved
0.7375 Intermediate Similarity NPD7458 Discontinued
0.7368 Intermediate Similarity NPD7251 Discontinued
0.7347 Intermediate Similarity NPD6007 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD6002 Phase 3
0.7338 Intermediate Similarity NPD6005 Phase 3
0.7338 Intermediate Similarity NPD6006 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD6003 Clinical (unspecified phase)
0.7338 Intermediate Similarity NPD6004 Phase 3
0.7333 Intermediate Similarity NPD6663 Approved
0.7326 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7326 Intermediate Similarity NPD7808 Phase 3
0.732 Intermediate Similarity NPD7033 Discontinued
0.7317 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.731 Intermediate Similarity NPD6797 Phase 2
0.7308 Intermediate Similarity NPD8166 Discontinued
0.7301 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7297 Intermediate Similarity NPD5736 Approved
0.7288 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD7240 Approved
0.7255 Intermediate Similarity NPD4978 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD7097 Phase 1
0.725 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7241 Intermediate Similarity NPD1091 Approved
0.7239 Intermediate Similarity NPD6801 Discontinued
0.7237 Intermediate Similarity NPD230 Phase 1
0.7233 Intermediate Similarity NPD8389 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.723 Intermediate Similarity NPD5647 Approved
0.7219 Intermediate Similarity NPD6233 Phase 2
0.7197 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7162 Intermediate Similarity NPD2797 Approved
0.7152 Intermediate Similarity NPD3268 Approved
0.7152 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7152 Intermediate Similarity NPD6798 Discontinued
0.7135 Intermediate Similarity NPD7799 Discontinued
0.7134 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD5763 Approved
0.7115 Intermediate Similarity NPD5762 Approved
0.7091 Intermediate Similarity NPD7819 Suspended
0.7089 Intermediate Similarity NPD3750 Approved
0.7081 Intermediate Similarity NPD6273 Approved
0.707 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7067 Intermediate Similarity NPD2861 Phase 2
0.7048 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7047 Intermediate Similarity NPD6362 Approved
0.7037 Intermediate Similarity NPD5403 Approved
0.703 Intermediate Similarity NPD1934 Approved
0.7025 Intermediate Similarity NPD1652 Phase 2
0.7013 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7013 Intermediate Similarity NPD5124 Phase 1
0.7012 Intermediate Similarity NPD7028 Phase 2
0.6994 Remote Similarity NPD5844 Phase 1
0.6988 Remote Similarity NPD2393 Clinical (unspecified phase)
0.6987 Remote Similarity NPD1510 Phase 2
0.6986 Remote Similarity NPD5126 Approved
0.6986 Remote Similarity NPD5125 Phase 3
0.6983 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6981 Remote Similarity NPD4109 Clinical (unspecified phase)
0.6981 Remote Similarity NPD4110 Phase 3
0.6974 Remote Similarity NPD5952 Clinical (unspecified phase)
0.697 Remote Similarity NPD7411 Suspended
0.6962 Remote Similarity NPD5958 Discontinued
0.6962 Remote Similarity NPD1549 Phase 2
0.6959 Remote Similarity NPD1608 Approved
0.6957 Remote Similarity NPD6799 Approved
0.6946 Remote Similarity NPD5402 Approved
0.6946 Remote Similarity NPD3817 Phase 2
0.6943 Remote Similarity NPD2935 Discontinued
0.6933 Remote Similarity NPD3094 Phase 2
0.6919 Remote Similarity NPD6168 Clinical (unspecified phase)
0.6919 Remote Similarity NPD6167 Clinical (unspecified phase)
0.6919 Remote Similarity NPD6166 Phase 2
0.6918 Remote Similarity NPD6674 Discontinued
0.6914 Remote Similarity NPD5401 Approved
0.6914 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6914 Remote Similarity NPD4378 Clinical (unspecified phase)
0.6909 Remote Similarity NPD6599 Discontinued
0.6905 Remote Similarity NPD7768 Phase 2
0.6899 Remote Similarity NPD1550 Clinical (unspecified phase)
0.6899 Remote Similarity NPD1552 Clinical (unspecified phase)
0.6898 Remote Similarity NPD7435 Discontinued
0.6894 Remote Similarity NPD7236 Approved
0.6894 Remote Similarity NPD5058 Phase 3
0.6887 Remote Similarity NPD2798 Approved
0.6883 Remote Similarity NPD4062 Phase 3
0.6879 Remote Similarity NPD7473 Discontinued
0.6875 Remote Similarity NPD7157 Approved
0.6872 Remote Similarity NPD8434 Phase 2
0.6872 Remote Similarity NPD8150 Discontinued
0.6871 Remote Similarity NPD3019 Approved
0.6871 Remote Similarity NPD2932 Approved
0.6867 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6867 Remote Similarity NPD1876 Approved
0.6865 Remote Similarity NPD7237 Clinical (unspecified phase)
0.6863 Remote Similarity NPD7095 Approved
0.6863 Remote Similarity NPD3027 Phase 3
0.6862 Remote Similarity NPD8320 Phase 1
0.6862 Remote Similarity NPD8319 Approved
0.6855 Remote Similarity NPD2424 Discontinued
0.6842 Remote Similarity NPD7585 Approved
0.6839 Remote Similarity NPD4060 Phase 1
0.6839 Remote Similarity NPD4140 Approved
0.6839 Remote Similarity NPD3751 Discontinued
0.6835 Remote Similarity NPD2438 Suspended
0.6835 Remote Similarity NPD6685 Approved
0.6835 Remote Similarity NPD2796 Approved
0.6831 Remote Similarity NPD969 Suspended
0.6821 Remote Similarity NPD3267 Approved
0.6821 Remote Similarity NPD3266 Approved
0.6821 Remote Similarity NPD7852 Clinical (unspecified phase)
0.6812 Remote Similarity NPD5909 Discontinued
0.681 Remote Similarity NPD2533 Approved
0.681 Remote Similarity NPD2534 Approved
0.681 Remote Similarity NPD2532 Approved
0.6809 Remote Similarity NPD2067 Discontinued
0.6809 Remote Similarity NPD7680 Approved
0.6806 Remote Similarity NPD2629 Approved
0.6806 Remote Similarity NPD690 Clinical (unspecified phase)
0.6804 Remote Similarity NPD7930 Approved
0.6802 Remote Similarity NPD6232 Discontinued
0.68 Remote Similarity NPD8470 Clinical (unspecified phase)
0.6797 Remote Similarity NPD4908 Phase 1
0.6795 Remote Similarity NPD4340 Discontinued
0.679 Remote Similarity NPD6652 Clinical (unspecified phase)
0.6789 Remote Similarity NPD7583 Approved
0.6788 Remote Similarity NPD7239 Suspended
0.6786 Remote Similarity NPD2801 Approved
0.6786 Remote Similarity NPD1358 Approved
0.6786 Remote Similarity NPD1465 Phase 2
0.6786 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6783 Remote Similarity NPD7843 Approved
0.6779 Remote Similarity NPD3092 Approved
0.6779 Remote Similarity NPD422 Phase 1
0.6779 Remote Similarity NPD3705 Approved
0.6774 Remote Similarity NPD8032 Phase 2
0.6772 Remote Similarity NPD2799 Discontinued
0.6772 Remote Similarity NPD3748 Approved
0.676 Remote Similarity NPD7090 Clinical (unspecified phase)
0.6757 Remote Similarity NPD17 Approved
0.6755 Remote Similarity NPD3225 Approved
0.675 Remote Similarity NPD4534 Discontinued
0.6747 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6739 Remote Similarity NPD6535 Approved
0.6739 Remote Similarity NPD6534 Approved
0.6739 Remote Similarity NPD6647 Phase 2
0.6738 Remote Similarity NPD6776 Approved
0.6738 Remote Similarity NPD6779 Approved
0.6738 Remote Similarity NPD6778 Approved
0.6738 Remote Similarity NPD6777 Approved
0.6738 Remote Similarity NPD6780 Approved
0.6738 Remote Similarity NPD6781 Approved
0.6738 Remote Similarity NPD6782 Approved
0.6737 Remote Similarity NPD7999 Approved
0.6735 Remote Similarity NPD7741 Discontinued
0.6731 Remote Similarity NPD1240 Approved
0.6731 Remote Similarity NPD1613 Approved
0.6731 Remote Similarity NPD1612 Clinical (unspecified phase)
0.673 Remote Similarity NPD6099 Approved
0.673 Remote Similarity NPD6100 Approved
0.672 Remote Similarity NPD7700 Phase 2
0.672 Remote Similarity NPD7699 Phase 2
0.6719 Remote Similarity NPD8151 Discontinued
0.6714 Remote Similarity NPD3134 Approved
0.6712 Remote Similarity NPD9493 Approved
0.671 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6707 Remote Similarity NPD7410 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data